Free Trial

BioPharma Credit (BOPCF) Short Interest Ratio & Short Volume

BioPharma Credit logo
$0.91 0.00 (0.00%)
(As of 11/7/2024 ET)

BioPharma Credit Short Interest Data

BioPharma Credit (BOPCF) has a short interest of 11,900 shares. This marks a 5,850.00% increase in short interest from the previous month. The short interest ratio (days to cover) is 4.4, indicating that it would take 4.4 days of the average trading volume of 274,765 shares to cover all short positions.

Current Short Interest
11,900 shares
Previous Short Interest
200 shares
Change Vs. Previous Month
+5,850.00%
Dollar Volume Sold Short
$10,710.00
Short Interest Ratio
4.4 Days to Cover
Last Record Date
September 15, 2024
Today's Trading Volume
0 shares
Average Trading Volume
274,765 shares
Today's Volume Vs. Average
0%
Short Selling BioPharma Credit?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for BioPharma Credit and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

BOPCF Short Interest Over Time

BOPCF Days to Cover Over Time

BOPCF Percentage of Float Shorted Over Time

BioPharma Credit Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/15/202411,900 shares $10,710.00 +5,850.0%N/A4.4 $0.90
8/31/2024200 shares $195.00 +100.0%N/A2 $0.98
8/15/2024100 shares $93.00 No ChangeN/A0 $0.93
7/31/2024100 shares $86.20 -97.5%N/A0 $0.86
7/15/20244,000 shares $3,448.00 -92.6%N/A0.8 $0.86
6/30/202454,000 shares $47,023.20 +53,900.0%N/A0.9 $0.87
6/15/2024100 shares $87.08 -50.0%N/A0 $0.87
5/31/2024200 shares $174.16 +100.0%N/A0 $0.87
5/15/2024100 shares $89.00 -50.0%N/A0 $0.89
4/30/2024200 shares $182.16 No ChangeN/A0 $0.91
4/15/2024200 shares $184.00 +100.0%N/A0 $0.92
3/31/2024100 shares $92.00 -50.0%N/A0 $0.92
3/15/2024200 shares $179.88 +100.0%N/A2 $0.90
2/29/2024100 shares $93.10 No ChangeN/A1 $0.93
8/15/20235,000 shares $4,350.00 No ChangeN/A0.1 $0.87
7/31/20235,000 shares $4,350.00 No ChangeN/A0.2 $0.87

BOPCF Short Interest - Frequently Asked Questions

What is BioPharma Credit's current short interest?

Short interest is the volume of BioPharma Credit shares that have been sold short but have not yet been covered or closed out. As of September 15th, traders have sold 11,900 shares of BOPCF short. Learn More on BioPharma Credit's current short interest.

What is a good short interest ratio for BioPharma Credit?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BOPCF shares currently have a short interest ratio of 4.0. Learn More on BioPharma Credit's short interest ratio.

Is BioPharma Credit's short interest increasing or decreasing?

BioPharma Credit saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 11,900 shares, an increase of 5,850.0% from the previous total of 200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($6.15 billion), Charter Communications, Inc. ($4.04 billion), Paychex, Inc. ($2.77 billion), Nu Holdings Ltd. ($2.71 billion), Cencora, Inc. ($2.34 billion), Aptiv PLC ($2.18 billion), Tractor Supply ($2.07 billion), International Paper ($2.01 billion), AppLovin Co. ($1.95 billion), and Moderna, Inc. ($1.89 billion). View all of the most shorted stocks.

What does it mean to sell short BioPharma Credit stock?

Short selling BOPCF is an investing strategy that aims to generate trading profit from BioPharma Credit as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against BioPharma Credit?

A short squeeze for BioPharma Credit occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BOPCF, which in turn drives the price of the stock up even further.

How often is BioPharma Credit's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BOPCF, twice per month. The most recent reporting period available is September, 15 2024.




This page (OTCMKTS:BOPCF) was last updated on 11/8/2024 by MarketBeat.com Staff
From Our Partners